PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Nrf2, SOD, CAT, GPx, GR, UCP3, CPT-1, and PGC-1α mRNA expression was significantly increased in the PA and Orlistat groups as compared to their expression in the NAFLD group (Figure 4B,C).